Introduction
Seizure disorders represent the most common neurologic problem in dogs and often present to general practitioners for initial evaluation. [1] [2] [3] The terms seizures and epilepsy are not synonymous. According to the ILAE in 2005, "an epileptic seizure is a transient occurrence of signs or symptoms due to abnormal excessive or synchronous neuronal activity in the brain." Whereas the ILAE defines epilepsy as "a disorder of the brain characterized by an enduring predisposition to generate epileptic seizures and by the neurobiologic, cognitive, psychological, and social consequences of this condition. The definition of epilepsy requires the occurrence of at least 1 epileptic seizure." [4] [5] [6] It has been reported that epilepsy is the most frequent diagnosis in dogs presenting with a history of new-onset seizures. 2, 3 However, there are many causes for epileptic seizures in the emergent patient. For owners of dogs with newly diagnosed epilepsy, common concerns reported to clinicians include the possible source of seizures, the risk of seizure recurrence, and prognosis. 5, 7 Thus, it is important for the practitioner to be comfortable with these causes and inform owners. Successful management of patients with seizures is facilitated by an appropriate diagnostic workup, which may vary patient to patient and is dictated by the list of differential diagnoses considered by the evaluating clinician. 8 This goal of this review is to discuss seizure classifications, diagnostics for epileptics in general practice and, briefly, treatments in the emergent setting for suspected epileptics. This is not intended to be a detailed review of differentials diagnoses and their treatments.
Classifications
The International Veterinary Epilepsy Task Force (IVETF) has recently reported on current epilepsy definition, classification and terminology in companion animals. 6 As previously mentioned, the terms seizure and epilepsy are not interchangeable. A seizure is the clinical manifestation of abnormal electrical activity in the brain. 4 A reactive (or provoked) seizure is a seizure occurring as a natural response from the normal brain to a transient disturbance in function, typically metabolic or toxic in nature. The responses are reversible when the cause is identified and treated appropriately. Epilepsy is defined as a disease of the brain characterized by an enduring predisposition to generate epileptic seizures. This definition is usually practically applied as having at least 2 unprovoked epileptic seizures 424 hours apart. 6 Focal epileptic seizures are theorized as originating within networks limited to one cerebral hemisphere. They may be discretely localized or more widely distributed and can progress to generalized seizures. Focal seizures have previously been referred to as partial seizures. Focal seizures have been shown to be difficult to diagnose amongst veterinarians. 9 Generalized epileptic seizures indicate involvement of both cerebral hemispheres. Generalized epileptic seizures are theorized as originating at some point within, and rapidly engaging, bilaterally distributed networks. Generalized seizures have previously been referred to as grand-mal seizures. They are often associated with convulsions (tonic-clonic, tonic, or clonic), loss of consciousness and salivation, urination, or defecation. These are the most common type of seizure recognized in animals. Acute repetitive, or cluster, seizures are classified as 2 or more epileptic seizures in a 24-hour period. 6 The most dangerous condition is known as status epilepticus (SE), in which epileptic seizures follow one another without recovery of consciousness between them or a seizure (ictal phase) lasting greater than 5 minutes. 6, 10, 11 Several classifications of epilepsy have been described, however, the 2 most commonly used by veterinarians are idiopathic epilepsy (IE) and structural epilepsy. IE is used when the nature is either known, or suspected to be, genetic in origin or when the underlying cause is unknown but with no indication of structural epilepsy. In the clinical setting IE remains most commonly a diagnosis of exclusion following diagnostic investigations for causes of reactive seizures and structural epilepsy. 12 Structural epilepsy is characterized by epileptic seizures which are provoked by intracranial (cerebral) pathology. This may include vascular, inflammatory or infectious, traumatic, anomalous or developmental, neoplastic, and degenerative diseases. Structural epilepsy can only be confirmed by diagnostic imaging, cerebrospinal fluid (CSF) examination, DNA testing, or postmortem findings. 6 However, the age at seizure onset and the presence of interictal neurologic abnormalities often suggest the likelihood of identifying structural cerebral disorders. In a study in a nonreferral canine population, structural epilepsy was statistically more probable in dogs o1 year or 47 years of age at seizure onset, whereas IE was statistically more probable in dogs aged 1-5 years at first seizure and when the interictal period was longer than 4 weeks. 6 In a retrospective study on a referral population of 240 dog with epileptic seizures, seizure onset between 1 and 5 years of age was associated with a 3.25 times greater likelihood for IE than structural epilepsy and reactive seizures.
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History, Clinical Presentation, and Examination
In order to diagnose IE, it is important to rule-out other causes of epileptic seizures in your patient. History, signalment, and neurologic examination findings allow a standardized diagnostic approach based on the clinical picture to help determine the underlying cause of seizures. 8 The most important first step for the practitioner is to determine if an epileptic seizure has occurred, as many other episodic disorders can mimic epileptic seizures; these include syncope, vestibular episodes, neuromuscular weakness, idiopathic head tremors or bobbing, cataplexy or narcolepsy, or even compulsive disorders. Thus, a detailed and accurate history of the event is the foundation for investigation of the seizure patient. The following are examples of important questions to consider when obtaining a history from the owner: When the first seizure was observed, what was the age of the patient and time of day? Was there any precipitating event (i.e., exercise and activity)? It is necessary to receive a complete description of the seizure (preictal, ictal, and postictal). Have the owners describe the pet's responsiveness to the owner during the episode. Ask about presence of autonomic signs (salivation, urination, defecation, vomiting), muscle tone, any facial involvement (eye movements, head tilt, or tremors), and evidence of lateralizing signs (one eye, one side of the face, one limb affected Because seizures may be a sign of a wide variety of problems, after a complete history is obtained, thorough physical and neurologic examinations are critical. The general physical examination should be aimed at finding signs of systemic or multifocal disease (fever and weight loss) that might suggest an underlying cause for the seizure. The key components of the neurologic examination include evaluation of mentation, gait and posture, cranial nerves, postural reactions, spinal reflexes, and cervical and thoracolumbar spinal palpation. The goal is to identify signs indicating structural disease of the forebrain, if present. 8 However, caution is advised when performing and interpreting the neurologic examination shortly after a seizure. Neurologic impairment may simply be a manifestation of transient ictal or postictal disturbances vs. permanent structural damages. If deficits are present, it is recommended to repeat the examination in 24-48 hours to ensure reproducibility and differentiate postictal effects from fixed interictal deficits.
Patients with primary epilepsy may present in SE or with acute repetitive (cluster) seizures as their first known seizure event; however, the presentation of SE or cluster seizures in a patient without previously observed or documented epilepsy should raise concern about underlying structural or metabolic disease. 8 
Diagnostic Tests
Based on accurate history and thorough examination, an appropriate list of differentials should be created by the clinician. For example, toxin ingestion or exposure or head trauma should be determined more, or less, likely based on detailed discussion and examination. If a patient is actively having a seizure, a rapid inhouse evaluation of blood glucose and electrolytes is useful to guide treatment for reactive seizures. The most common cause of epileptic seizures in the dog is IE. Once epilepsy is suspected, the following diagnostics should be recommended to the owner in order to rule out metabolic causes of seizures: a complete blood count, serum biochemical profile, fasted preprandial and postprandial bile acids, serum ammonia, urinalysis, and blood pressure. As structural epilepsy cannot be diagnosed without advanced diagnostics, referral to a veterinary neurologist for additional testing such as magnetic resonance imaging (MRI) and CSF analysis should also be offered to the owner. Infectious disease titers can be considered based on geographical area and travel history; certain infectious disease tests are both sensitive and specific when performed on blood or urine, whereas others are more sensitive when performed on CSF. However, if there is not a strong clinical suspicion for structural disease, the owner may elect not to pursue additional testing with the guidance of the practitioner. In such cases, patients can be presumed to have IE and treated symptomatically for seizures, if appropriate. If at any point the dog is refractory to therapy, it should be strongly recommended for owners to pursue referral for MRI and discussion on additional antiepileptic drug (AED) therapy. 8, 11 The International Veterinary Epilepsy Task Force suggests three tiers of confidence in the diagnosis of IE. 12 Tier I confidence level includes: history of 2 or more unprovoked epileptic seizures occurring at least 24 hours apart, age at epileptic seizure onset of between 6 months and 6 years, unremarkable interictal physical and neurologic examination (except for AED induced neurologic abnormalities and postictal neurologic deficits), and no clinically significant abnormalities on minimum data base blood tests (CBC and serum chemistry profile), and urinalysis. Tier II level consists of unremarkable fasting and postprandial bile acids, MRI of the brain and CSF analysis in addition to factors listed in tier I. The final tier, III, involves the identification of ictal or interictal electroencephalogram (EEG) abnormalities characteristic for seizure disorders according to criteria validated in human medicine, in addition to factors listed in tier I and II. However, this is not commonly performed in clinical veterinary practice. 12 
Client Education
Once epilepsy is diagnosed client education is, arguably, almost as important as the diagnosis itself because success of treatment depends more on the owner than any other variable. 11 The objectives of treatment are a reduction of seizure frequency and intensity with minimal adverse effects. If IE is suspected, owners should be made aware that it is typically a chronic disorder in that it's course and direction are difficult to predict. They should be informed that their dog will still seizure on AED medication and what seizure control means in the context of their animal. The advantages and disadvantages of treatment should be explained. The objectives of AED therapy, and simple fundamentals of pharmacokinetics should be carefully reviewed with the owner and reiterated as necessary on subsequent visits. The medication must be taken regularly or not at all. The owner should always be warned not to suddenly stop giving AEDs, no matter how long the interval since the last seizure due to the risk of precipitating SE. The owner needs to know what medications are prescribed, their dose and side effects and what constitutes an emergency. 14 It has been described that the diagnosis of epilepsy implies an increased risk of premature death. The prognosis for dogs with epilepsy is dependent on a combination of veterinary expertise, therapeutic response, and the owner's motivation. 15 A recent study, 16 revealed that overall, owners of dogs with epilepsy reported positive quality of life. However, quality of life was lower for dogs with severe or poorly controlled epilepsy and medication-related adverse effects. Despite the financial burden involved in managing a dog with epilepsy, monthly medication cost was not associated with their quality of life. This information gives a better understanding of the needs of dogs with epilepsy and the support that their owners seek, as well as the education of owners related to the care and treatment of a dog recently diagnosed with epilepsy. 16 If structural epilepsy is suspected, owners must be informed that AED therapy will not treat the underlying cause, but only aid in the control of seizure activity. Prognosis depends on the diagnosis, but is often worse compared to IE.
Treatment
In the ideal setting, treatment to control seizure activity should be postponed until after a complete neurologic examination can be performed as many of the drugs can affect the patient's mentation, gait, proprioception, or reflexes. If a patient presents during a seizure and necessitates medication administration before examination, it is important to note this when recording your examination findings later. If a metabolic cause for reactive seizures is identified, such as hypoglycemia, that should be rapidly and directly treated.
In the emergent setting, benzodiazepines should be given as emergent initial therapy. 17, 18 Typically, boluses of midazolam or diazepam are administered first. Both diazepam and midazolam are dosed at 0.5 mg/kg IV, but higher doses (1 mg/kg) should be used if the dog is on maintenance phenobarbital therapy. Midazolam can also be administered intranasally at 1 mg/kg via an atomizer and diazepam can be administered rectally at the same dose. 18 Benzodiazepine boluses can be repeated, but after 3 times it is recommended to reach for a longer-acting drug. It is important to remember that diazepam or midazolam only have AED effects that last roughly 15 minutes. If in SE, an IV constant rate infusion of diazepam or midazolam can be considered, though a maintenance AED should be given at this time because benzodiazepines do not give long term seizure control. Here, the bolus dose should be administered first, followed by an infusion of ≥0.2 mg/kg/h IV. Vagal maneuvers have been described in dogs, though they are controversial as little literature currently supports their use. 19, 20 Following discussion with the owner or pending patient's status, a maintenance AED should be administered either intravenously or orally. Intravenous phenobarbital takes 15-30 minutes to take effect. Thus, it may be beneficial to the patient to receive both a benzodiazepine and phenobarbital at the same time. If seizures stop, continue maintenance dosing of phenobarbital. 21 Phenobarbital is discussed above because of the availability of the intravenous form and common use in veterinary medicine. The loading dose for phenobarbital is 16 mg/kg and can be administered as a single bolus or divided into 4 doses over 24 hours. Maintenance dosing of phenobarbital is ≥2.2 mg/kg IV or PO BID for dogs and will take 10-14 days to reach steady state. 22, 23 Levetiracetam is another medication to consider when intravenous administration is required. It can be administered with a higher initial dose to quickly increase the plasma concentration of the drug 24 and give rapid seizure control. Levetiracetam comes in various formulations, but the injectable and regular tablets are most useful in the emergent scenario. It can be administered at ≥20 mg/kg IV or PO TID. Single large boluses of levetiracetam can be used for the emergent seizure patient at 60 mg/kg IV. Keep in mind that concurrent administration of phenobarbital increases the metabolism and clearance of levetiracetam, so doses should be increased in those patients. 25, 26 In difficult cases that are not responsive to benzodiazepines, phenobarbital or levetiracetam, there are various other drugs that can be used. Ketamine has been reported to control seizure activity on EEG. 27 Propofol is controversial as it has been shown to stop the motor manifestations of seizures, but does not always ablate EEG seizure activity. 28, 29 Inhalant anesthesia, isoflurane in particular, can be used as a last resort to control seizure activity at the depth of general anesthesia. 30 Often, the patient does not present with active seizures and thus, time allows for conversations and oral administration of AED of choice. There are multiple AEDs available to the general practitioner. A recent study by the authors of this review (in press), determined that a majority of board-certified criticalists and neurologists initiate therapy with phenobarbital as their firsttime AED of choice with levetiracetam as the second most common for both groups.
The ACVIM consensus statement 31 on seizures discusses the medications available and gives general recommendations for when to initiate treatment. Their recommendations are that AED therapy should be initiated when the following occurs: (1) identifiable structural lesion present or prior history of brain disease or injury; (2) acute repetitive seizures or, SE (ictal event ≥5 minutes or ≥3 or more generalized seizures within a 24-hour period); (3) ≥2 or more seizure events within a 6-month period; and (4) prolonged, severe, or unusual postictal periods. It is recommended to institute initial therapy with a single drug as introduction of more than 1 variable at a time precludes assessment of both therapies and increases the risk of side effects. Ideally, one drug is "optimized," used at the ideal dose, frequency and blood level, before another of an additional AED. Disadvantages of using multiple agents include increased cost, the need to monitor and interpret serum concentrations of multiple drugs, potential drug interactions, and more complicated dosing schedules. Nonetheless, some patients will become refractory to initial therapy and may require a combination of drugs. 11 It is often helpful to consult a board-certified neurologist on seizure management with refractory patients.
Conclusion
Determining if a patient has true epileptic activity and classifying it appropriately based on history and examination are instrumental in the proper diagnosis for the seizuring patient. Although diagnostics and treatment are important for the patient, client education should be a priority for the general practitioner. Ultimately the decision to initiate AED therapy should be guided by the practitioner on a case by case basis. If the patient is suspected to have IE, advanced diagnostics or referral may not be necessary for every case. However, not initiating therapy, not recommending referral for complete diagnostics when concerned for structural epilepsy or not consulting with a specialist when the patient is refractory to treatment, may be detrimental to the patient's outcome. As this review article does not describe pharmacokinetics or review on each AED available, it is suggested for the general practitioner to refer to the ACVIM consensus statement 31 and other peer-reviewed literature for more detailed information.
